Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Bristol-Myers Squibb
Bristol-Myers Squibb
4 Solid Pharmaceutical Dividend Plays
Seeking Alpha
Thu, 09/16/10 - 06:27 am
dividends
Eli Lilly
Pfizer
GSK
Bristol-Myers Squibb
Savient Investors Expect a Sale
TheStreet.com
Wed, 09/15/10 - 08:06 am
Savient
M&A
gout
FDA
Krystexxa
JNJ
Pfizer
Amgen
Novartis
Bristol-Myers Squibb
Idenix Hopes to Resume Course With Hepatitis C Drugs by Year's End
Seeking Alpha
Sun, 09/12/10 - 11:17 am
Idenix
hepatitis C
Bristol-Myers Squibb
ZymoGenetics
Vertex Pharmaceuticals
Telaprevir
Regulus
GSK
Merck
Bristol-Myers Pays A Premium For Its Partner
Investopedia
Sat, 09/11/10 - 11:35 am
Bristol-Myers Squibb
ZymoGenetics
Merck Serono
Novo Nordisk
Bristol-Myers starts tender offer for ZymoGenetics
Yahoo/AP
Fri, 09/10/10 - 11:09 am
ZymoGenetics
M&A
Bristol-Myers Squibb
BMS: Is This Drugmaker a Lavish Spender or a Bargain Hunter?
Motley Fool
Wed, 09/8/10 - 02:57 pm
Bristol-Myers Squibb
ZymoGenetics
M&A
ZymoGenetics shares soar 84 percent
Bizjournals.com
Wed, 09/8/10 - 01:41 pm
ZymoGenetics
Bristol-Myers Squibb
M&A
Biggest Battles in Biopharma
Fierce Pharma
Wed, 09/8/10 - 11:33 am
Sun Pharma
Taro
Pfizer
Warner-Lambert
Aventis
Sanofi-Synthelabo
Astellas
OSI Pharmaceuticals
King
Alpharma
Novartis
Carl Icahn
Bristol-Myers Squibb
Alcon
Genzyme
Bristol-Myers Agrees to Acquire ZymoGenetics for $885 Million
NY Times, NY
Tue, 09/7/10 - 09:29 pm
Bristol-Myers Squibb
M&A
ZymoGenetics
Glaxo's Avandia Should Be Pulled From U.K. Market, BMJ Chief Editor Says
Bloomberg
Mon, 09/6/10 - 10:11 am
GSK
Avandia
diabetes
Bristol-Myers Squibb
Does Bristol-Meyers Squibb Pass Buffett's Test?
Motley Fool
Mon, 09/6/10 - 10:07 am
Warren Buffett
Bristol-Myers Squibb
The 7 Most Popular High Yielders in Pharma
Motley Fool
Thu, 09/2/10 - 08:50 pm
Pfizer
JNJ
Merck
Abbott Laboratories
Bristol-Myers Squibb
GSK
Novartis
The 15 Highest-Yielding Pharma & Biotech Stocks
Motley Fool
Thu, 09/2/10 - 09:24 am
PDL Biopharma
Eli Lilly
Sanofi
GSK
Bristol-Myers Squibb
AstraZeneca
Pfizer
Merck
Novartis
JNJ
Abbott Laboratories
Pharmaceutical Product Development
Techne
Biovail
Novo Nordisk
Pipeline Review: Bristol-Myers Squibb's 5 Keys to Success
Motley Fool
Wed, 09/1/10 - 08:51 am
Bristol-Myers Squibb
Plavix
generics
5 Drugmakers With Killer Dividends
Motley Fool
Wed, 09/1/10 - 06:46 am
dividends
Pfizer
Merck
JNJ
Eli Lilly
Bristol-Myers Squibb
Catalyst for Pfizer and Bristol Expected in 2011
Minyanville
Tue, 08/31/10 - 05:38 pm
Pfizer
Bristol-Myers Squibb
Apixaban
21 Drugs Facing FDA Approval Decisions
TheStreet.com
Tue, 08/31/10 - 12:05 pm
FDA
Questcor Pharmaceuticals
Savient
Alkermes
Arena Pharmaceuticals
Roche
Novartis
Hospira
Human Genome
Alexza
Jazz Pharmaceuticals
Biodel
Amylin
Eli Lilly
Vivus
Avanir
Cadence Pharmaceuticals
Amgen
Cumberland
Orexigen
MannKind
Bristol-Myers Squibb
AstraZeneca says blood thinner met key study goals
Yahoo/AP
Mon, 08/30/10 - 10:32 am
blood thinners
AstraZeneca
FDA
Ticagrelor
Sanofi
Plavix
Bristol-Myers Squibb
The Cancer Trial Bristol and Roche Must Do Now
Forbes
Thu, 08/26/10 - 06:21 pm
Roche
cancer
Bristol-Myers Squibb
Gleevac
ipilimumab
Pfizer, Bristol-Myers to present apixaban data
Yahoo/AP
Wed, 08/25/10 - 06:48 pm
Pfizer
Apixaban
Bristol-Myers Squibb
blood thinners
Pages
« first
‹ previous
…
97
98
99
100
101
102
103
104
105
…
next ›
last »